Tulrampator - RespireRx Pharmaceuticals/Servier
Alternative Names: Ampakine-CX-1632; CX-1632; S47445Latest Information Update: 29 Jan 2020
At a glance
- Originator Cortex Pharmaceuticals
- Developer ADIR; Servier
- Class Antidementias; Antidepressants; Benzoxazines; Cyclopropanes; Fluorobenzenes; Small molecules; Triazines
- Mechanism of Action AMPA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Dementia; Major depressive disorder; Mild cognitive impairment
Most Recent Events
- 29 Jan 2020 Discontinued - Phase-I for Alzheimer's disease in France (PO) before January 2020 (Servier website, January 2020)
- 29 Jan 2020 Discontinued - Phase-I for Dementia in France (PO) before January 2020 (Servier website, January 2020)
- 29 Jan 2020 Discontinued - Phase-I for Mild cognitive impairment in France (PO) before January 2020 (Servier website, January 2020)